Company: IXHL
Filing Date: 2025-05-28
Form Type: 8-K
Source: 0001213900-25-047988
Chunk: 7

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-28
Form: 8-K
Item: Item 9.01
Chunk 7
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                                                       
         1.1+      Amended and Restated Sales Agreement, dated May 27, 2025, by and among Incannex Healthcare Inc., A. G. P./Alliance Global Partners and Curvature Securities, LLC  
          3.1      Certificate of Amendment to Amended and Restated Certificate of Incorporation of Incannex Healthcare Inc., dated May 27, 2025.                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          5.1      Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C.                                                                                                   
         10.1      Form of Second Letter Agreement.                                                                                                                                  
         10.2      Amendment No. 1 to Incannex Healthcare Inc. 2023 Equity Incentive Plan.                                                                                           
         23.1      Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C. (included in Exhibit 5.1)                                                                         
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                       

  Schedules and exhibits have been omitted pursuant to Item 601(a)(5)                                                                            

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                          Incannex Healthcare Inc.                                             
  Date: May 28, 2025      /s/ Joel Latham                                                      
                          Name:                         Joel Latham                            
                          Title:                        Chief Executive Officer and President